🔎 Trials Near Me

Hem › Övervikt › Florida › Orlando

Kliniska studier för Övervikt i Orlando, FL

31 studier för Övervikt söker deltagare vid platser i och runt Orlando (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekryterarFas 2
  • Charter Research - Winter Park /ID# 281968, Orlando
  • Florida Institute For Clinical Research /ID# 282739, Orlando
Ålder 18 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07752979

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Rekryterar
  • Orlando Health, Inc., Orlando
Ålder 21 till 65 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07090005

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

RekryterarFas 1Friska volontärer välkomna
  • Kailera Clinical Site, Orlando
Ålder 18 till 85 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07793929

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

RekryterarFas 2
  • Florida Institute For Clinical Research, LLC, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi bort
  • Omega Research Orlando, Altamonte Springs · 9 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

RekryterarFas 3
  • Florida Institute for Clinical Research, LLC, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

RekryterarFas 2
  • Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 mi bort
  • K2 Medical Research Maitland LLC, Main Office, Maitland · 6 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

RekryterarFas 2
  • Clinical Neuroscience Solutions, Orlando
Ålder 18 till 75 · Alla kön · Uppdaterad 28 sep. 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RekryterarFas 3
  • Clinical Neuroscience Solution, Orlando
  • Florida Institute for Clinical Research, LLC, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

RekryterarFas 3
  • Florida Inst For Clin Res LLC, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07668414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekryterarFas 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

RekryterarFas 3
  • Florida Hospital- Center for Pediatric Research, Orlando
  • Nemours Children's Health, Orlando
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekryterarFas 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

RekryterarFas 3
  • Clinical Neuroscience Solution, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekryterarFas 3
  • Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

RekryterarFas 3
  • Research Site, Ocoee · 10 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekryterarFas 3
  • West Orange Endocrinology, Ocoee · 10 mi bort
Ålder 45 till 99 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

RekryterarFas 3
  • Conquest Research, Winter Park · 5 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekryterarFas 2
  • Charter Research - Winter Park, Orlando
Ålder 18 till 75 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RekryterarFas 3
  • AURORA-1 Clinical Site, Winter Park · 5 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RekryterarFas 3
  • AURORA-2 Clinical Site, Winter Park · 5 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

RekryterarFas 3
  • AdventHealth Orlando, Orlando
  • Orlando Health Heart Institute, Orlando
  • Guardian Research Organization LLC, Winter Park · 5 mi bort
  • och 1 fler
Ålder 18 till 99 · Alla kön · Uppdaterad 16 sep. 2026 · NCT07037459

Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households

Rekryterar
  • University of Central Florida, Orlando
Ålder 5 till 11 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07464015

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

RekryterarFas 3Friska volontärer välkomna
  • ACCOMPLISH-2 Research Site, Ocoee · 10 mi bort
Ålder 18 till 79 · Alla kön · Uppdaterad 11 sep. 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekryterarFas 2
  • Charter Research - Winter Park, Orlando
Ålder 18 till 75 · Alla kön · Uppdaterad 8 sep. 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

RekryterarFas 3
  • Kailera Clinical Site, Orlando
  • Kailera Clinical Site, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekryterarFas 3
  • Clinical Neuroscience Solutions - Orlando, Orlando
  • Combined Research Orlando Phase I IV, Orlando
  • Florida Institute for Clinical Research, Orlando
Ålder 18 till 99 · Alla kön · Uppdaterad 3 sep. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

RekryterarFas 3
  • Florida Institute for Clinical Research, Orlando
  • Conquest Research - Winter Park, Winter Park · 5 mi bort
Ålder 18 till 99 · Alla kön · Uppdaterad 3 sep. 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

RekryterarFas 3
  • Clinical Neuroscience Solutions, Orlando
  • Florida Institute for Clinical Research, Orlando
Ålder 18 till 99 · Alla kön · Uppdaterad 27 aug. 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

RekryterarFas 3
  • Cardiovascular Institute of Orlando, Orlando
  • Guardian Research Org LLC, Winter Park · 5 mi bort
  • K2 Medical Research, Maitland · 6 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

RekryterarFas 3
  • ACCOMPLISH-1 Research Site, Ocoee · 10 mi bort
Ålder 18 till 79 · Alla kön · Uppdaterad 10 aug. 2026 · NCT07654361

Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise

RekryterarFriska volontärer välkomna
  • AdventHealth Translational Research Institute, Orlando
Ålder 18 till 45 · Alla kön · Uppdaterad 27 mars 2026 · NCT06602141

Övervikt-studier i andra städer

Andra studier i Orlando

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.